More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...

The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...

Still, TV remains the industry's primary advertising format, with over $4 billion spent in the past year, led by blockbuster ...

A recent study that found there has been a massive increase in type 2 diabetes cases worldwide since 1990 is an indication that the market for GLP-1 drugs could likely be ... Lilly also market their ...

From constipation to muscle loss, the side effects of some weight loss and diabetes medications can be daunting to patients.

Scrolling through photos from my husband ... talk of GLP-1 and semaglutide drugs, like Ozempic, causing hair loss, but ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

GLP-1 Receptor Agonist medications, such as Ozempic, combined with exercise and nutrition, can help reduce obesity, according ...

The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...